Skip to main content
OSG logo

OSG

Octave Specialty Group Inc
$6.13 +0.11 (+1.83%) At close · Jul 13
Market Cap
$275.93M
Shares
45,013,592

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.13 Open$6.03 Day$5.96–6.18 52W$3.88–10.38 Avg vol 30d508K Short int1.3M · 2.9% float · 1.7d Short vol48% Last earningsMay 6, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 6
Up next
Next earnings call
Aug 5, 2026 Est · unconfirmed · in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 6, 2026
Equibles Rating blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 17.2 · elevated Equity put/call 0.67
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −7%
below
Price vs 50-day avg +8%
above
RSI (14) 54
neutral
MACD trend Negative
52-week position 35%
mid-range
Momentum
relative strength
Weak
1-month return +11%
trailing
6-month return +1%
trailing
YTD return −21%
this year
Relative strength −7%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $6 › 200d $7 — 200d above 50d
Institutional flow Distributing
5 of 148 funds reported for Jun 30 · net -13.0K sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.91% of float · ▲ +22.1% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
148 holders — mid 3-yr range
Squeeze score 53
elevated · 0–100
Fundamentals
Strong
Revenue growth +7%
Y/Y
EPS growth +50%
Y/Y
Buyback $8.4M
remaining
Balance sheet $88.0M
net debt
Quant / Vol
risk profile
Very High
Volatility 71%
annualized · 1-yr
Max drawdown −61%
past year
ATR 4.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−7% Bearish
Price vs 50-day avg
+8% Bullish
RSI (14)
54 Neutral
MACD trend
Negative Bearish
52-week position
35% Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $6 › 200d $7 — 200d above 50d
Institutional flow Distributing
5 of 148 funds reported for Jun 30 · net -13.0K sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.91% of float · ▲ +22.1% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
148 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $4 Now $6 · 35% 52-wk high $10
vs 200-day avg -7% vs 50-day avg +8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings
Metric Latest Period YoY
Adjusted EBITDA margin to shareholders (Insurance Distribution) non-GAAP 32% Q1 2026
Adjusted EBITDA to Shareholders (Everspan) non-GAAP 1.6M Q1 2026
Adjusted EBITDA to Shareholders (Insurance Distribution) non-GAAP 25M Q1 2026
Adjusted net income (Everspan) non-GAAP 1.2M Q1 2026
Gross premiums written (Everspan) 104M Q1 2026
Loss ratio (Everspan active programs) 57% Q1 2026
Net premiums written (Everspan) 32M Q1 2026
Organic revenue growth (Insurance Distribution) 42% Q1 2026
Pre-tax income margin to shareholders (Insurance Distribution) 16% Q1 2026
Total revenue (Insurance Distribution Segment) 79M Q1 2026
adjusted EBITDA to shareholders non-GAAP $20.1M Q1 2026 call
adjusted EBITDA to shareholders margin non-GAAP 32.3% Q1 2026 call
adjusted net income to shareholders non-GAAP $16.6M Q1 2026 call
adjusted net income to shareholders per share non-GAAP $0.37 Q1 2026 call
Everspan accident year loss ratio 54% Q1 2026 call
Everspan active programs loss ratio 57% Q1 2026 call
Everspan adjusted EBITDA non-GAAP $2M Q1 2026 call
Everspan combined ratio 95% Q1 2026 call
Everspan gross premiums written $104M Q1 2026 call
Everspan net premiums earned $20M Q1 2026 call
Everspan net premiums written $32M Q1 2026 call
Insurance Distribution adjusted EBITDA non-GAAP $25M Q1 2026 call
Insurance Distribution adjusted EBITDA to shareholders non-GAAP $25.3M Q1 2026 call
Insurance Distribution debt to EBITDA (pro forma TTM) 3.2 March 31, 2026 call
Specialty Property & Casualty adjusted EBITDA non-GAAP $1.6M Q1 2026 call
Insurance Distribution Segment Adjusted EBITDA to Shareholders non-GAAP $7M the fourth quarter
Insurance Distribution Segment Commission Income $37M the fourth quarter
Insurance Distribution Segment Organic revenue growth 8.1% the fourth quarter
Specialty P&C Insurance (Everspan) Gross premiums written $80M the fourth quarter
Specialty P&C Insurance (Everspan) Net premiums written $23M the fourth quarter

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Insurance - Specialty — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OSG
Octave Specialty Group Inc
this stock
$275.93M -21.2% +132.6% 2.9%
FNF
Fidelity National Financial, Inc.
$13.47B -6.3% +5.6% 17.8 3.3%
RYAN
Ryan Specialty Holdings, Inc.
$11.01B -18.8% +21.3% 5.7%
AXS
Axis Capital Holdings Ltd
$8.44B +7.4% +9.9% 8.6 3.0%
FAF
First American Financial Corp
$7.14B +15.0% +21.6% 10.8 6.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
148
% held
73.6%
Reported
5 of 148
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
135
View
Short & Settlement
Short Interest Rising
Shares short
1.3M
Days to cover
1.7d
Change
+236.6K sh
View
Short Volume
Short vol %
48%
As of
Jul 14, 2026
Short Total
View
Fails to Deliver
FTD shares
20
Value
$111
As of
Jun 10, 2026
View
Off-Exchange
Off-exchange %
41.7%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$251.2M
Net income (FY)
$-259.1M
EPS diluted
$-5.93
View
Buybacks
Authorized
$50.0M
Remaining
$8.4M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
May 29, 2026
This year
8
View
Proposed Sales
Value
$1.4M
Shares
105.6K
Filed
Jun 26, 2023
View
Earnings & Events
Earnings Calls
Last call
May 6, 2026
View
Investor Relations
Latest news
Octave Specialty Group Reports Fi…
Published
May 6, 2026
View

Performance

5D 20D 120D MTD YTD
OSG -4.5% +10.9% +1.2% -1.8% -21.2%
SPY -0.3% +1.6% +8.3% +0.3% +9.9%
vs SPY -4.2% +9.3% -7.2% -2.1% -31.1%

Capital returns

Buyback program · as of Mar 31, 2026
Authorized
$50.00M
Spent (derived)
$41.55M
Remaining
$8.45M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 874501 CUSIP 023139884 13F (30d) 4 filings 4 filers Visit website Investor relations